SBI Life, a unit of top Indian lender State Bank of India (SBI), will open the share sale to the public on Sept. 20 and close it on Sept. 22, according to a filing.
The shares, that will begin trading Oct. 3, will be sold in a price range of 685-700 rupees apiece, raising as much as 84 billion rupees ($1.3 billion) for SBI Life’s main shareholders — SBI and BNP Paribas Cardif — which are paring their stakes.
Strong stock markets have fueled a surge in equity deals in Asia’s third-largest economy, with IPO proceeds so far this year exceeding $3 billion. While last year’s $4 billion fundraising from IPOs is set to be surpassed, some expect proceeds to even top the record $8.5 billion raked in seven years ago.
High inflows, including from retail investors into equity markets, are driving sectors that historically never listed in India to explore IPOs, said Arun Kejriwal, founder of Kejriwal Research & Investment Services.
“This augurs well for the capital markets. However, a note of caution: valuations are steep,” Kejriwal added.
SBI Life’s IPO, the third insurer to list in the country, will be the biggest since state-run Coal India’s 155 billion rupee ($2.4 billion) IPO in 2010.
ICICI Lombard General Insurance Co.’s IPO to raise up to $890 million opens on Friday, while HDFC Standard Life Insurance is expected to hit the markets in the coming weeks with what is likely to be another billion-dollar offering.
That will be followed by two other big insurer listings — state-run reinsurer General Insurance Corp. of India (GIC Re) and non-life insurer New India Assurance Co., estimated to raise a total of more than $3 billion.
While the insurers are betting on lower penetration and rising income levels bolstering demand for their products, the government’s plan to pare its stake in five state-run general insurers through IPOs is also going to drive offerings.
In the SBI Life IPO, SBI is selling up to an 8 percent stake, while BNP Paribas Cardif is selling up to 4 percent. The two currently own 70 percent and 26 percent, respectively.
The IPO price range values the insurer at about $11 billion, versus the $7 billion valuation at which SBI sold a nearly 4 percent stake to KKR and Temasek in December.